Member Info for idkmybffjill

This doesn’t seem a little crazy to anyone? We won’t get full year results for the previous year until half way through the current year?

Anyone know when they will end up posting FY2022 results? It was supposed to come in mid April, correct? But got put off due to the acquisition?

What divy’s?

Revenue growth continues to be very strong.

Repurchasing uses up cash though. I’d prefer them to refi for now to bring down interest rate?

will they refinance Mime’s debt? I can’t imagine AA wants to keep paying 10% interest on their debt

The mime debt Kistos is inheriting has a 10% interest rate. Really high? Can Kistos refinance this?

Would AA want to sell this for 6.50 given how he did with Rockrose?

Two Seas Capital LP seeks to generate outsized, uncorrelated returns through investments in events with a legal or regulatory catalyst. Two Seas Global Fund, its Flagship commingled vehicle, launched 1Q 2021 to build a balanced portfolio with attractive risk/return attributes.

Baby hippos are cute but what’s the connection to Indivior? Lol

Seems like stock started rallying right after Tango Cash said the company sucked lol

I am surprised they don’t pre announce a date

Wouldn't shareholders just reject a deal?

Tango-Cash, did you sell yet? Please do. It seems like the stock is ready to move up after you are out lol

Lol only thing that changed is stock dropped. Tango Cash should take himself out of the market, since his entire investment philosophy is narrative following price.

Look through the list of outstanding action in any pharma company’s profile.

More money in the US than UK, getting added to major indices (which means lots of passive money buying the stock), more healthcare focused investors, more sell side coverage, etc.

Also, Pfizer is a slow growth behemoth. Why should it be valued at a high PE? Not sure why that would even be the comparison.

Cashola, can you rephrase what you said? I don’t get it.

“ Firstly, he acquires a company by paying £8m and announces immediately thereafter a cash balance of $127m”

Can any of you share the details surrounding this transaction?

Okay so basically have nothing concrete, besides saying the stock price is down and therefore everything about the company sucks.

They just finished the second buyback. Litigation is a fact of life for every pharma company.

Do you have something actually legitimate besides the stock price dropping? Price is driving your narrative.